Clinical Trials Directory

Trials / Unknown

UnknownNCT04548414

Homocysteine in Patients With Sepsis

The Effect of Homocysteine on the Prognosis of Patients With sepsis-an Observational Study

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Nanjing University of Traditional Chinese Medicine · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

After stimulation by lipopolysaccharide (LPS), the one-carbon metabolism of macrophages was significantly up-regulated, the expression of key enzyme 5,10-methylenetetrahydrofolate reductase increased. In vitro experiments we found that LPS stimulation can increase the expression of MTHFR mRNA and protein in macrophages, suggesting that aerobic glycolysis may trigger cytokine storm through one-carbon metabolism. Homocysteine (homocysteine, Hcy) is an important intermediate product of one-carbon metabolism. A number of studies have shown that Hcy is positively correlated with the level of pro-inflammatory factors, significantly enhancing cytokine storm. However, the relationship between Hcy and serum pro-inflammatory factors in patients with sepsis and the effect of Hcy on the prognosis of patients with sepsis are still unclear. Based on the previous work, our research group intends to carry out single-center, prospective, observational clinical research to observe the relationship between homocysteine and the mortality of patients with sepsis, and to provide new indicators for accurately judging the prognosis of sepsis , To provide new targets for clinical development of drugs for the treatment of sepsis.

Conditions

Interventions

TypeNameDescription
OTHERNo.This is an observational study with no intervention.

Timeline

Start date
2020-09-20
Primary completion
2022-05-19
Completion
2022-09-19
First posted
2020-09-14
Last updated
2020-09-14

Source: ClinicalTrials.gov record NCT04548414. Inclusion in this directory is not an endorsement.